From November 20, 2023 to December 31, 2023, the company has repurchased 7,201,500 shares, representing 1.35% for CNY 95.84 million. With this, the company has completed the repurchase of 7,201,500 shares, representing 1.35% for CNY 95.84 million under the buyback announced on November 20, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.96 CNY | -0.99% | -5.08% | -33.28% |
May. 10 | ChenGuang Biotech Group Co., Ltd. Approves Cash Dividend for the Year 2023 | CI |
Apr. 24 | ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.28% | 634M | |
-1.63% | 277B | |
-5.38% | 91.92B | |
-4.35% | 42.95B | |
+1.09% | 41.25B | |
+6.11% | 40.01B | |
+5.54% | 38.81B | |
-13.54% | 30.87B | |
-11.47% | 27.21B | |
+8.91% | 24.19B |
- Stock Market
- Equities
- 300138 Stock
- News ChenGuang Biotech Group Co., Ltd.
- Tranche Update on ChenGuang Biotech Group Co., Ltd.'s Equity Buyback Plan announced on November 20, 2023.